These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34943946)

  • 1. Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese
    Makarova E; Kazantseva A; Dubinina A; Denisova E; Jakovleva T; Balybina N; Bgatova N; Baranov K; Bazhan N
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Same Metabolic Response to FGF21 Administration in Male and Female Obese Mice Is Accompanied by Sex-Specific Changes in Adipose Tissue Gene Expression.
    Makarova E; Kazantseva A; Dubinina A; Jakovleva T; Balybina N; Baranov K; Bazhan N
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of fibroblast growth factor 21 are sex-specific in mice with the lethal yellow (A
    Makarova EN; Yakovleva TV; Balyibina NY; Baranov KO; Denisova EI; Dubinina AD; Feofanova NA; Bazhan NM
    Vavilovskii Zhurnal Genet Selektsii; 2020 Mar; 24(2):200-208. PubMed ID: 33659800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet.
    Gao M; Ma Y; Cui R; Liu D
    J Control Release; 2014 Jul; 185():1-11. PubMed ID: 24747761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
    Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y
    Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism.
    Wanders D; Forney LA; Stone KP; Burk DH; Pierse A; Gettys TW
    Diabetes; 2017 Apr; 66(4):858-867. PubMed ID: 28096260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
    Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
    Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice.
    Krumm CS; Xu X; Bare CJ; Holman CD; Kersten S; Dow LE; Lee AH; Cohen DE
    J Biol Chem; 2021 Jul; 297(1):100815. PubMed ID: 34023388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21.
    Kim EK; Lee SH; Jhun JY; Byun JK; Jeong JH; Lee SY; Kim JK; Choi JY; Cho ML
    Mediators Inflamm; 2016; 2016():5813030. PubMed ID: 27057099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice.
    Goto T; Hirata M; Aoki Y; Iwase M; Takahashi H; Kim M; Li Y; Jheng HF; Nomura W; Takahashi N; Kim CS; Yu R; Seno S; Matsuda H; Aizawa-Abe M; Ebihara K; Itoh N; Kawada T
    J Biol Chem; 2017 Jun; 292(22):9175-9190. PubMed ID: 28404815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF21 gene therapy as treatment for obesity and insulin resistance.
    Jimenez V; Jambrina C; Casana E; Sacristan V; Muñoz S; Darriba S; Rodó J; Mallol C; Garcia M; León X; Marcó S; Ribera A; Elias I; Casellas A; Grass I; Elias G; Ferré T; Motas S; Franckhauser S; Mulero F; Navarro M; Haurigot V; Ruberte J; Bosch F
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29987000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway.
    Wang ZQ; Zhang XH; Yu Y; Tipton RC; Raskin I; Ribnicky D; Johnson W; Cefalu WT
    Metabolism; 2013 Sep; 62(9):1239-49. PubMed ID: 23702383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity.
    Wang L; Mazagova M; Pan C; Yang S; Brandl K; Liu J; Reilly SM; Wang Y; Miao Z; Loomba R; Lu N; Guo Q; Liu J; Yu RT; Downes M; Evans RM; Brenner DA; Saltiel AR; Beutler B; Schnabl B
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15184-15193. PubMed ID: 31289229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
    Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
    Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying sex differences in responses to fibroblast growth factor 21 administration in obese mice consuming a sweet-fat diet.
    Bazhan NМ; Jakovleva TV; Kazantseva AY; Kostina NE; Orlov PE; Balybina NY; Baranov KО; Makarova EN
    Vavilovskii Zhurnal Genet Selektsii; 2023 Jul; 27(4):333-341. PubMed ID: 37469453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats.
    Wang WF; Li SM; Ren GP; Zheng W; Lu YJ; Yu YH; Xu WJ; Li TH; Zhou LH; Liu Y; Li DS
    Endocrine; 2015 May; 49(1):119-29. PubMed ID: 25306889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
    Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ
    Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.